AIM ImmunoTech Inc. — Director's Dealing 2012

May 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-05-10

Reporting Person: KIANI IRAJ EGHBAL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-10	Common Stock	J	11062	$2.26	Acquired	257333	Direct
2012-05-10	Common Stock	J	5208	$2.4	Acquired	262541	Direct

Footnotes

F1: Shares received in payment for services as a Director of Hemispherx.